Skip directly to content

NEWS

TAG Welcomes Price Reductions For TB Medicines
June 19, 2018 – Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.

Research Toward a Cure
June 15, 2018  A regularly updated listing of clinical trials and observational studies related to the research effort to cure HIV infection.

JOB OPPORTUNITY – TAG Development Manager
May 15, 2018 – TAG is seeking to hire a dynamic Development Manager who'll report to the Deputy Executive Director – Development and Operations. The Development Manager will work closely with TAG’s Executive Director, Board of Directors, the Development Committee, and program directors, and oversee and enhance a robust development program as well as directing TAG’s annual fundraising campaign, major gifts, annual benefit, smaller events, and in-print and digital appeals.

Sign-On Letter: Advocacy to End Peace Corps HIV Dismissals
May 15, 2018 – Sign our letter to Dr. Josephine Olsen, Director of the Peace Corps, about their policies and practices regarding volunteers newly diagnosed with HIV.

Webinar: Ending the Epidemic - Building Effective Collaboration between Community Advocates and Health Departments
May 15, 2018 – Register now for this free webinar on May 31.

Affordable Medicines Now Conference: June 27–29, 2018
Affordable Medicines Now is a training conference designed to build skills, knowledge and community among the activists who power the movement for affordable medicines at the state, federal, and international levels.

Tools To Help Support Activists in Engaging National Policy Makers on TB
May 3, 2018 – We just added two great new tools: a brief on TB R&D needs and key asks, and a brief on pediatric TB needs and key asks.

Webinar: Ending the Epidemic - Update on Implementing the New York State Blueprint
April 25, 2018 – On April 13th, 2018 TAG and Housing Works hosted a discussion with New York EtE leadership to review recent successes in implementing the Blueprint, assess policy advocacy for the coming year, and explore plans to address shortcomings. All the webinar materials are available for download now.

Now Available in Spanish: Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV
April 4, 2018 – You can now download a Spanish version of our Training Manual for Treatment Activists: Hepatitis C and HIV Coinfection!

TAGline Spring 2018
NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS

INTERNSHIP OPPORTUNITY: Hepatitis C Virus (HCV) Program Internship
March 29, 2018 – Treatment Action Group seeks a dynamic summer intern to support the hepatitis C virus program. This is an unpaid internship position and would be suitable to serve as course credit.

Now Available in French and Slide Decks Added: Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV
March 28, 2018 – You can now download a French version of our Training Manual for Treatment Activists: Hepatitis C and HIV Coinfection, and view or download PDFs of slide decks of every chapter of the English version.

TAG Statement on Final Appropriations for Fiscal Year 2018
March 23, 2018 – TAG lauds Congress on rejecting the President’s anti-science rhetoric.

New York Community Groups Call on City, State, Federal Actors to Increase Funding for Tuberculosis
March 22, 2018 – 
Advocates alarmed that budget cuts led to first rise in TB cases in New York City in over 25 years.

Webinar: “It’s Time to Deliver - Including Pregnant and Lactating Women in Clinical Research"
March 22, 2018 –
Materials from Part II are available now.
 

TAG LIMITED ART EDITIONS 1999-2017 Exhibition opened Wednesday March 21, and is running through Saturday March 24 at Westbeth Gallery in New York City. Get the full details here.
 

TAG Applauds Governor Cuomo's Commitment to Eliminate Hepatitis C and Expansion of Enhanced Rental Assistance for People Living with HIV in New York State.
March 16, 2018 – Read the full statement.

Is Shorter Better? Understanding the Shorter Regimen for Treating Drug-Resistant Tuberculosis
March 12, 2018 – Confused about the shorter regimen for treating Multidrug-resistant TB (MDR-TB)? We were too, so we worked with DR-TB STAT on a brief to understand its pros and cons.

ACTION NEEDED: False Hope - Protect Your Right to Safe, Effective Medicines by Stopping the "Right to Try" Movement
March 5, 2018 – The Senate already passed a False Hope bill (The Right to Try Act of 2017), and we anticipate a similar bill will go to the House soon. Many patients need experimental medicines before they're approved, but the U.S. Food and Drug Administration (FDA) already has a very effective mechanism for allowing for early access.

TAG Issue Brief: Suboptimal Immune Recovery on Antiretroviral Therapy
March 5, 2018 - Antitretroviral therapy is highly effective at suppressing HIV viral load, but for some individuals this does not lead to adequate reconstitution of the immune system. TAG's issue brief offers an overview of suboptimal immune recovery on antiretroviral therapy, and explains why it remains an important concern.

Civil society calls on Novartis to end 'bullying tactics' and respect countries' legal rights to make medicines more affordable
March 1, 2018 – TAG rises in solidarity with 11 civil society organizations around the world in opposing the menacing and obstructive tactics by the pharmaceutical giant, Novartis, which seeks to undermine countries' affordable access to medicines.

Webinar: It's Time to Deliver - Including Pregnant and Lactating Women in Clinical Research, Pt 1
February 21, 2018 – Pregnant women have frequently been excluded from or de-prioritized in clinical research initiatives due to a multitude of factors, such as the complex physiology of pregnant women, the risk studies may pose to the fetus, and the classification of pregnant women as a vulnerable population, among others. Part I of this webinar series was was intended to broaden and build the capacity of civil society and other partners interested in issues related to pregnant and lactating women and research.

NY State Medicaid Director Announces Potential Path for Volume Based Deal to Expand Hepatitis C Treatment at Lower Price
February 16, 2018 –  On Monday, February 12th, New York State Medicaid Director Jason Helgerson made news by announcing a potential path forward in the State’s response to its major hepatitis C epidemic at the joint Senate/Assembly budget hearing on Health and Medicaid.

Statement on POTUS FY19 Budget Release
February 13, 2018 – Treatment Action Group released a statement today in which it vehemently opposes cuts in the Trump administration’s fiscal year (FY) 2019 budget proposal. Those cuts severely threaten the accelerated progress of recent years towards ending the domestic and global HIV/AIDS, tuberculosis (TB) and hepatitis C virus (HCV) epidemics.

Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide
February 5, 2018 – We recently released this innovative new guide for people who have tuberculosis (TB), people who are at risk for it, and the people who take care of them.

Updated Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV
February 1, 2018 – We've just released an updated Training Manual for Treatment Activists: Hepatitis C and HIV Coinfection. The purpose of this Training Manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and care and treatment for, hepatitis C virus (HCV).

Letter from Health Organizations: NAFTA Renegotiations Must Not Undermine Access to Affordable Medicines
January 26, 2018 – A group of 97 International, U.S., Canadian, and Mexican health organizations sent this letter to representatives of those countries, asking them to ensure that any North American Free Trade Agreement (NAFTA) renegotiations don’t undermine access to affordable medicines.

Letter to Gilead Sciences Opposing Unethical Patient Assistance Program Policy for Truvada for Postexposure Prophylaxis
January 25, 2018 – Gilead Sciences is limiting access to Truvada as a component of nonoccupational postexposure prophylaxis (nPEP) through its patient assistance program to once in a lifetime, with hardship review criteria and processes for subsequent prescriptions that have not been clearly articulated and are likely a considerable barrier to nPEP by uninsured and underinsured U.S. residents.

Discriminatory Conscience and Religious Freedom Division Proposed Rule Threatens Our Most Vulnerable Communities
January 19, 2018 – TAG is alarmed by recent actions taken by the Trump administration to subvert the health and wellbeing of women, transgender individuals, and marginalized communities in America.

Webinar: Good COPs or Bad COPs? Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs)
January 18, 2018 – Every year, PEPFAR meets to discuss their strategy and budget for the following year, and set targets on implementing country operation plans (COPs) to improve the response to HIV/AIDS. This webinar held on Thursday, January 11 provides key information regarding the PEPFAR COPs process and timelines, TB/HIV services covered by PEPFAR, and what civil society and advocates should prioritize for inclusion in COPs.

TAG Mourns the Loss of Mathilde Krim, PhD
January 16, 2018 – TAG mourns the loss of an inspirational, tireless, catalytic leader of our movement. Dr. Krim understood the gravity of the epidemic, in its earliest and darkest days, and was driven by her own remarkable intelligence, fierce commitment to civil rights and social justice, extraordinary social and political networks, and true grit to galvanize funders, scientists, policy leaders, and activists toward a single cause: ending HIV and AIDS as a threat to humanity.

Securing a Tuberculosis-Free Future through the Visionary Research of the CDC’s Tuberculosis Trials Consortium
January 10, 2018 – CRAG, the community advisory board to the Tuberculosis Trials Consortium has produced a useful new brief to raise awareness of the TBTC’s accomplishments, show major advancements in TB care resulting from TBTC studies, and make the case for increasing TB research funding at CDC.

TAG Joins Call to Oppose U.S. Secretary of Health and Human Services Appointment
January 5, 2018 —In advance of a U.S. Senate Committee on Finance hearing on January 9, 2018, TAG and over 60 other civil society organizations issued a statement asking U.S. senators to oppose the confirmation of Alex Azar as Secretary of Health and Human Services.

Ending the HIV/AIDS Epidemic
December 26, 2017 – We now have evidence-based tools for HIV treatment and prevention that are so effective that they could conceivably end the most deadly infectious disease epidemic in modern history. Many community leaders across the United States are calling for just that: an end to the HIV/AIDS epidemic in their cities, their counties, and their states.

Hasty Passage of the Tax and Health Care Bill
December 22, 2017 – With the hasty passage of the tax and health care bill passed along party lines yesterday afternoon, Congress has sent a clear message on how they prioritize communities living with and vulnerable to HIV, tuberculosis (TB), and hepatitis C virus (HCV) in the upcoming mid-term election year.

TAG Statement on Forbidden Words in Budget Documents
December 20, 2017 – Treatment Action Group (TAG) joins the chorus of rational voices expressing outrage at reports that HHS agencies have received instructions to avoid words unpalatable to the Trump administration in their budget requests.

TAG Statement to Human Rights Council on Human Rights Concerns in the UAE
December 18, 2017
 – On December 13, 2017, TAG participated in a hearing in Geneva, Switzerland to brief members of the Human Rights Council on human rights concerns in the United Arab Emirates (UAE).

Webinar: Exploring the Implications of the Delamanid Phase III and STREAM Trial Results
December 14, 2017
 – The first ever phase III trials for multidrug-resistant TB (MDR-TB) finally yielded results. Treatment Action Group (TAG), ACTION, and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) presented the results in a Webinar held on December 12, 2017.

2017 Symposium: Reframing Risk and Accountability for Action to ZERO TB
December 14, 2017
– On October 12, 2017, in Guadalajara, Mexico, Treatment Action Group, Advanced Access & Delivery, Harvard Medical School, Partners In Health, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference on Lung Health.

HIV Cure Research Information Sheet
December 14, 2017
 – A TAG information sheet on the current state of research into curing HIV infection. 

TAGline Fall 2017
NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS

Sign the Declaration Calling for Drug Decriminalization to Achieve Hepatitis Elimination
December 4, 2017 – At the World Hepatitis Summit in São Paulo, Brazil, a large coalition of hepatitis patients, representatives of the drug using community, medical providers, researchers, and public health experts expressed their whole-hearted support to the commitment of the World Health Organization (WHO)’s goal to eliminate viral hepatitis by 2030. 

Changing World Health Organization Global TB Program Leadership
December 1, 2017
– TAG's Executive Director, Mark Harrington, congratulates Dr. Mario Raviglione on his retirement and thanks him for his efforts and the years of collaboration while he was director of the World Health Organization’s (WHO's) Global TB Program.

TAGupdate
December, 2017 – TAG's progress on the fight to end HIV/AIDS, viral hepatitis, and tuberculosis.

Suboptimal Immune Recovery on Antiretroviral Therapy: Causes, Consequences, & the Search for Solutions
November 29, 2017 – Video and slides from a webinar presented by TAG's Basic Science, Vaccines and Cure Project Director Richard Jefferys and Nelson Vergel from the Program for Wellness Restoration. 

Remarks by Erica Lessem on TB research at the WHO Global Ministerial Conference on Ending TB
November 27, 2017
– In remarks delivered at the first-ever WHO Global Ministerial Conference on Ending Tuberculosis (TB), TAG's Deputy Executive Director of the TB Project, Erica Lessem, describes the urgent need for civil society to drive political action on funding TB R&D, by drawing from lessons and successes of the HIV movement.

The Ascent Begins: Tuberculosis Research Funding Trends, 2005–2016
November 8, 2017 – Global funding for TB research reached a previously unreported high of $726 million in 2016, according to TAG's latest Tuberculosis Research Funding Trends report. This represents a $100 million increase over 2015 levels and marks the first time annual funding for TB research and development (R&D) has exceeded $700 million since TAG began tracking spending in 2005. Although higher than in previous years, this amount remains woefully inadequate when judged against the innovation gaps holding back the response to TB, which is the world’s leading cause of death from a single infectious agent.

End the Epidemic Resources: Southern States EtE Meeting Summary and FAQs
November 2, 2017 – In May, TAG, the Southern AIDS Coalition, the Southern HIV/AIDS Strategy Initiative, Sisterlove, and AIDS Alabama, and the National Alliance of State and Territorial AIDS Directors (NASTAD) held a consultation with more than 40 community advocates and key stakeholders from across the Deep South to assess the major challenges and opportunities for EtE planning. Several key findings from that meeting can be found in this summary report. Included here is a document addressing the frequently asked questions we often get about the EtE campaigns.
 
Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics
October 31, 2017 – A summary of the July 2017 Hepatitis C World Community Advisory Board meeting on the HCV landscape and the significant barriers—such as financing, awareness, complicated and unaffordable diagnostics, centralized service delivery, and stigma—that obstruct the sustainable scaling up of prevention, testing, and treatment services.
 
US Health & Human Services (HHS) Strategic Plan FY 2018-2022: TAG Comments to the Assistant Secretary for Planning and Evaluation
October 27, 2017 – TAG comments submitted to the Strategic Planning Team at the Office of the Assistant Secretary for Planning and Evaluation regarding the HHS Strategic Plan FY 2018-2022. The HHS Strategic Plan should set a precedent for reducing the burden of disease nationally through its focus on access to affordable treatment, advancement of research, implementation of evidence-based interventions, expansion of populations served, and inclusion of all stakeholders.
 
Tools to help support activists in engaging national policy makers on TB
October 25, 2017 - Two unprecedented political opportunities are rapidly approaching– the Global Ministerial Conference and the UN High Level Meeting on TB. Civil society and community groups have a critical role to play in raising the profile and understanding of the issues we face in TB among government officials and ensuring that the commitments they make at high-level meetings are translated into urgent investments and actions. To facilitate engagement between civil society and community groups and national policy makers, TAG has created tools and resources to help support grassroots efforts.


Submission to the Office of the United Nations High Commissioner for Human Rights to Report on Sustainable Development Goals and Health
October 16, 2017 – A review of comments submitted by TAG to the Office of the United Nations High Commissioner for Human Rights, in response to a request for submissions from interested organizations and stakeholders for the preparation of its report on Sustainable Development Goals and Health.

TAG HIV Basic Science, Vaccines, and Cure Project Blog Updates
October 12, 2017 – Effects of the anti-inflammatory antibody canakinumab on heart disease and cancer. Are there implications for HIV?

Take Action: #StopRTT Social Media Advocacy Toolkit
October 3, 2017 – Join TAG and our partners and take action by tweeting at members of the House of Representatives Energy & Commerce Subcommittee on Health to urge that they withdraw their support and block dangerous "Right to Try" bills (H.R. 1020) from advancing. Your Representatives need to hear from you! 

Letter to House E&C Subcommittee Opposing "Right to Try" Bills
October 3, 2017 – Right-to-Try legislation does nothing for people who are terminally ill. It instead aims to curtail vital FDA stringency requirements that have not only largely succeeded in protecting public health, but continue to be effectively streamlined to hasten access to investigational and approvable drugs and biologics for those who need them most.

HIV Research in the Era of PrEP: The Implications of TDF/FTC for Biomedical Prevention Trials
September 27, 2017 – A new paper from TAG on the questions surrounding implementation of Truvada pre-exposure prophylaxis (PrEP) in clinical trials of biomedical prevention interventions. 

TAG Applauds Malaysian Government's Decision to Make Generic form of Life-Saving Hep C Cure
September 20, 2017 The Government of Malaysia reaffirmed its commitment to affordable access to hepatitis C treatment by issuing a compulsory license on sofosbuvir (Sovaldi). TAG lauds this landmark decision for enabling the entry of generic competition, which will effectively reduce prices.

September 11, 2017 - The Activist's Guide to the TB LAM Test is written to help support advocacy and activism efforts aimed at  encouraging the uptake of the LAM test across regulatory agencies, donor-funded programs, and National AIDS and TB Progams. This guide discusses LAM as a critically important, true point-of-care diagnostic designed to detect TB in people living with HIV (PLHIV) with low CD4 counts. While providing strategies and messaging to ensure access to this vital diagnostic for people living with both HIV and TB.